The Bank of New York Mellon
BNY
$143.75
-1.13%
Bank of New York Mellon Corporation (BNY) is a global financial services holding company operating through two primary segments: Securities Services and Market and Wealth Services, providing custody, fund administration, asset servicing, clearing, collateral management, and investment management to institutions, corporations, and individual investors across 35 countries and more than 100 markets. As the world's largest global custody bank, with approximately $59.3 trillion in assets under custody and administration and roughly $2.2 trillion in assets under management, BNY occupies a systemically important, fee-based infrastructure position in the financial ecosystem that is distinct from traditional lending-focused money-center banks. The current investor narrative centers on the durability of BNY's fee revenue against a backdrop of elevated interest rates, the company's aggressive capital return program (roughly $1.1 billion in quarterly buybacks plus a $453 million dividend), and the market's debate over whether the stock's extraordinary multi-year re-rating has run ahead of fundamentals. With the shares up more than 1,300% over the trailing year on a total-return basis and trading near all-time highs, attention has shifted to whether margin expansion, operating leverage, and custody-market share gains can sustain the valuation premium, particularly after a sharp 10% one-month pullback that has reintroduced questions about near-term momentum and positioning.…
BNY
The Bank of New York Mellon
$143.75
Investment Opinion: Should I buy BNY Today?
The synthesized recommendation is Hold, balancing the stock's strong margin expansion and sustainable capital return against revenue stagnation and a stretched valuation. The analyst consensus is 'buy' with an average target of $166.93 (14.8% upside), but the recent 10.27% one-month pullback and relative underperformance versus SPY suggest near-term caution. The core thesis is that BNY's fee-based custody franchise is resilient, but the stock has already priced in significant optimism, leaving limited margin for error.
Supporting evidence includes the dramatic margin improvement (gross margin up to 55.99% from 48.07% YoY), a low PEG ratio of 0.561, a well-covered 2.06% dividend yield with a 30.37% payout ratio, and $1.556 billion in quarterly capital return. However, revenue declined 1.66% YoY in Q2 2026, and free cash flow yield is under 2%, which are red flags for a stock trading at 15.56x trailing earnings. The forward PE of 14.17x implies only modest earnings growth, and the price-to-book of 1.85x is near historical highs.
The biggest risks that could invalidate the thesis are a continued revenue decline, multiple compression toward the 11-13x PE range, and a slowdown in buyback activity. The rating would upgrade to Buy if revenue growth turns positive and the PE compresses below 14x, or downgrade to Sell if revenue declines accelerate beyond 3% and free cash flow remains weak. Relative to its own history and peers, BNY appears fairly valued to slightly overvalued, with the market pricing in optimistic expectations for margin expansion and capital return.
Sign up to view all
BNY 12-Month Price Forecast
BNY presents a balanced risk/reward profile: the company's margin expansion and capital return are impressive, but revenue stagnation and a stretched valuation limit upside. The recent 10.27% pullback has cooled momentum, and the stock now trades at 67.5% of its 52-week range, suggesting consolidation. Analyst sentiment remains constructive, but the wide target range ($135-$184) reflects disagreement about the durability of the re-rating. I would upgrade to bullish if revenue growth turns positive and the PE remains below 16x, or downgrade to bearish if revenue declines accelerate and free cash flow remains weak.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Bank of New York Mellon's 12-month outlook, with a consensus price target around $166.07 and implied upside of +15.5% versus the current price.
Average Target
$166.07
0 analysts
Implied Upside
+15.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$135 - $184
Analyst target range
Coverage on BNY is solid, with 14 analysts contributing to the consensus. The recommendation distribution skews bullish, with a consensus recommendation of "buy" and a recommendation mean of 2.125 (on a scale where lower is more bullish). The average target price is $166.93, which implies approximately 14.8% upside from the current price of $145.40. This is a constructive consensus, reflecting analyst confidence that the recent pullback represents a buying opportunity rather than the start of a deeper deterioration. The institutional ratings flow supports this view, with Truist Securities reiterating Buy on September 25, 2026, JP Morgan maintaining Overweight on August 4, 2026, and B of A Securities and Argus Research both carrying Buy ratings through July 2026.
The target range runs from a low of $135.00 to a high of $184.00, a spread of $49.00, or roughly 36% of the low target. The high target of $184 implies about 26.5% upside and likely assumes continued margin expansion, sustained buyback-driven EPS accretion, and possibly multiple expansion toward the upper end of the historical band. The low target of $135 implies about 7.2% downside and appears to price in fee compression, slower capital return, or a more challenging rate environment that pressures net interest income. The wide spread signals meaningful disagreement about the durability of the re-rating, which is consistent with a stock that has moved this far this fast. Notably, the recent ratings actions are overwhelmingly reiterations rather than upgrades or downgrades, indicating that analysts are holding their positions while waiting for the next catalyst, and the estimated average revenue of $24.48 billion for the forward period suggests the Street expects modest top-line stabilization rather than a return to strong growth.
Bulls vs Bears: BNY Investment Factors
The bear case currently has stronger near-term evidence due to the sharp momentum breakdown (-10.27% in one month) and revenue stagnation (-1.66% YoY), which contrast with the stock's extraordinary 1,324% one-year gain. However, the bull case is supported by improving margins (gross margin up to 55.99% from 48.07%), a sustainable capital return program, and analyst consensus targeting 14.8% upside. The single most important tension is whether BNY can reignite revenue growth or continue relying on margin expansion and buybacks to justify its premium valuation. If revenue remains flat, the risk of multiple compression toward the 11-13x PE range seen in 2024-2025 is significant. Conversely, any acceleration in fee revenue or net interest income could validate the re-rating and drive the stock toward the $184 high target.
Bullish
- Analyst Consensus Sees 14.8% Upside: The average analyst target price is $166.93, implying 14.8% upside from the current $145.40, with a consensus recommendation of 'buy' (mean 2.125) from 14 analysts. Recent reiterations from Truist Securities (Buy, Sep 25, 2026), JP Morgan (Overweight, Aug 4, 2026), and B of A Securities (Buy, Jul 2026) suggest institutional confidence remains intact despite the recent pullback.
- Dramatic Margin Expansion: Gross margin expanded to 55.99% in Q2 2026 from 48.07% in Q2 2025, while operating margin improved to 22.24% from 17.74% over the same period. Net income rose to $1.761 billion from $1.423 billion year-over-year, demonstrating strong operating leverage despite flat revenue.
- Attractive PEG Ratio of 0.561: The PEG ratio of 0.561 suggests the stock is undervalued relative to its earnings growth rate, a rare signal for a large-cap financial. With a forward PE of 14.17x and trailing PE of 15.56x, the valuation remains reasonable for a company with improving profitability.
- Sustainable Capital Return Program: BNY returned $1.103 billion in buybacks and $453 million in dividends in Q2 2026 alone, funded by $2.462 billion of operating cash flow. The dividend yield of 2.06% with a conservative payout ratio of 30.37% provides income support and room for future increases.
Bearish
- Revenue Stagnation Threatens Re-rating: Q2 2026 revenue declined 1.66% year-over-year to $10.192 billion, continuing a multi-quarter trend of stagnation with revenue hovering between $9.863 billion and $10.364 billion. The stock's 1,324% one-year gain has been driven by multiple expansion, not top-line growth, leaving little room for disappointment.
- Extreme Valuation Re-rating: The trailing PE has expanded 58% over two years, from 9.82x in Q2 2024 to 15.56x currently, while price-to-book has risen from 1.10x to 1.85x. This places the stock near the top of its historical valuation band, vulnerable to multiple compression if growth or capital return slows.
- Weak Free Cash Flow Generation: Trailing twelve-month free cash flow is only $1.592 billion against a market cap of $81.8 billion, an FCF yield of under 2%. Quarterly FCF has been highly volatile, swinging from -$3.63 billion in Q1 2026 to +$1.975 billion in Q2 2026, raising questions about cash flow sustainability.
- Momentum Breakdown and Relative Underperformance: The stock is down 10.27% over the past month and 0.83% over three months, underperforming SPY by 10.86 and 4.17 percentage points respectively. This sharp deceleration from a parabolic advance signals potential mean-reversion and profit-taking.
BNY Technical Analysis
BNY is in a powerful, sustained uptrend that has carried the stock from a 52-week low of $103.11 to a 52-week high of $165.84, a range spanning roughly 61%. At the current price of $145.40, the shares sit at approximately 67.5% of that 52-week range, meaning they are in the upper-middle portion of the band but have surrendered meaningful ground from the highs. The trailing one-year price change of +1,324.09% is extraordinary and reflects a massive re-rating rather than ordinary cyclical recovery, which means the stock is highly sensitive to any change in the growth or rate narrative that drove that move. The fact that price is no longer pressing the 52-week high suggests the momentum phase has cooled and the stock is now consolidating rather than extending.
Short-term momentum has clearly decelerated and now diverges sharply from the longer-term trend. The one-month change is -10.27% and the three-month change is -0.83%, both of which stand in stark contrast to the +1,324.09% one-year gain and the +1,333.93% year-to-date gain. This divergence is the single most important technical signal in the data: a stock that has risen more than 13-fold over a year but is down double digits in the past month is exhibiting classic mean-reversion or profit-taking behavior after a parabolic advance. Relative strength confirms the deterioration, with BNY underperforming SPY by 10.86 percentage points over the past month and by 4.17 points over three months, even though it remains ahead of SPY by 1,309.08 points over the full year. The most recent session did show a modest bounce, with the stock up 1.03% on the day, but that is a single-session move against a firmly negative monthly trend.
Key technical levels are well defined by the 52-week range. Support sits near the $103.11 52-week low, with intermediate support likely around the $143-$145 area where the stock has recently been oscillating; a breakdown below $143 would open the door toward the $135 analyst low and potentially the $120s. Resistance is anchored at the $165.84 52-week high, and a decisive breakout above that level would signal renewed institutional accumulation and likely require a fresh fundamental catalyst. With a beta of 1.048, BNY's volatility is roughly in line with the broader market, so the recent 10% monthly drawdown is stock-specific rather than a function of elevated market sensitivity. The maximum drawdown of -12.69% over the period is consistent with the current pullback and suggests the correction, while painful, remains within normal consolidation parameters for a stock that has run this far.
Beta
1.05
1.05x market volatility
Max Drawdown
-12.8%
Largest decline past year
52-Week Range
$103-$166
Price range past year
Annual Return
+1313.5%
Cumulative gain past year
| Period | BNY Return | S&P 500 |
|---|---|---|
| 1m | -12.8% | +0.6% |
| 3m | -6.0% | +3.6% |
| 6m | +1309.3% | +14.6% |
| 1y | +1313.5% | +15.8% |
| ytd | +1317.7% | +13.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BNY Fundamental Analysis
BNY's revenue trajectory is essentially flat to slightly declining, which is the central tension in the investment case. The most recent quarter (Q2 2026, ended June 30, 2026) generated $10.192 billion in revenue, down 1.66% year over year from $10.364 billion in Q2 2025. Looking across the multi-quarter trend, revenue has hovered in a narrow band: $9.863 billion in Q1 2026, $10.067 billion in Q4 2025, $10.359 billion in Q3 2025, and $10.364 billion in Q2 2025, indicating stagnation rather than growth. Within the segment mix, Financial Service is by far the largest contributor at $2.864 billion, followed by Investment Advisory, Management and Administrative Service at $796 million and Distribution and Shareholder Service at just $38 million, meaning the company's fortunes are overwhelmingly tied to the core servicing franchise. The flat top line implies that the stock's massive re-rating has been driven by margin expansion and capital return rather than revenue growth, which raises the bar for future earnings delivery.
Profitability is solid and, importantly, improving on a margin basis. Q2 2026 net income was $1.761 billion on $10.192 billion of revenue, a net margin of 17.28%, up from 13.73% in Q2 2025 and 13.95% in Q3 2025. Gross margin has expanded meaningfully, reaching 55.99% in Q2 2026 versus 48.07% in Q2 2025 and 48.34% in Q3 2025, while operating margin improved to 22.24% from 17.74% a year earlier. The company is clearly profitable and the direction of travel is favorable, with EBITDA rising to $2.666 billion in Q2 2026 from $2.265 billion in Q2 2025. For a custody and asset-servicing business, a high-teens net margin and low-20s operating margin are respectable but not exceptional, reflecting the scale-driven, fee-based nature of the model where incremental revenue drops through at high incremental margins.
Balance sheet and cash flow metrics present a more nuanced picture. The debt-to-equity ratio of 0.764 is moderate for a financial institution, and ROE of 12.52% is healthy, though ROA of just 1.26% reflects the balance-sheet-intensive nature of custody banking. Free cash flow is a concern: trailing twelve-month FCF is only $1.592 billion against a market cap of roughly $81.8 billion, implying an FCF yield of under 2%, and quarterly FCF has been highly volatile, swinging from -$3.63 billion in Q1 2026 to +$1.975 billion in Q2 2026. The current ratio of 0.704 is below 1.0, which is typical for banks but signals limited short-term liquidity cushion. Positively, the company is returning substantial capital to shareholders, with $1.103 billion of buybacks and $453 million of dividends in Q2 2026 alone, funded by $2.462 billion of operating cash flow, suggesting the dividend and repurchase program are sustainable even if FCF generation is lumpy.
Quarterly Revenue
$10.2B
2026-06
Revenue YoY Growth
-1.7%
YoY Comparison
Gross Margin
56.0%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BNY Overvalued?
Because BNY is solidly profitable with positive net income of $1.761 billion in the most recent quarter, the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 15.56x and a forward PE of 14.17x, a relatively narrow gap that implies the market expects only modest earnings growth over the next twelve months. The forward discount of roughly 9% is not the kind of steep compression typically seen in high-growth names, which is consistent with a mature, fee-based financial infrastructure business. The PEG ratio of 0.561 is notably low, suggesting that when growth is factored in, the stock screens as inexpensive relative to its earnings expansion rate.
On a peer-comparison basis, BNY's valuation sits at a premium to some traditional banking metrics but is not stretched on an absolute basis. The price-to-book ratio of 1.85x and price-to-sales ratio of 2.02x are moderate for a large-cap financial, and the trailing PE of 15.56x is broadly in line with the mid-teens multiple typical of large custody and trust banks. The dividend yield of 2.06% with a payout ratio of just 30.37% is comfortably covered and above the sector average, providing income support. The EV/Sales of -1.33 and EV/EBITDA of -1.78 are negative because of the bank's large net cash and deposit position, which distorts enterprise-value-based comparisons and makes them unreliable for this business model; investors should focus on PE, PB, and dividend metrics instead.
Historically, BNY's valuation has expanded dramatically. The trailing PE of 15.56x compares with 11.68x in Q2 2025, 12.31x in Q4 2024, and 9.82x in Q2 2024, meaning the multiple has re-rated by roughly 58% over two years. The price-to-book ratio has moved from 1.10x in Q2 2024 to 1.85x currently, and the price-to-sales ratio has climbed from 4.55x to 2.02x on the current data set (though historical PS readings above 8x in 2026 reflect different share-count and revenue bases). The stock is clearly near the top of its own historical valuation band, which means the market is pricing in optimistic expectations for margin expansion and capital return. This leaves limited room for disappointment; any slowdown in buyback pace, fee compression, or rate-driven revenue headwinds could trigger multiple compression back toward the 11-13x range seen in 2024-2025.
PE
15.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-1.8x
Enterprise Value Multiple
Investment Risk Disclosure
BNY faces financial and operational risks primarily stemming from revenue stagnation and weak free cash flow. Revenue declined 1.66% year-over-year in Q2 2026 to $10.192 billion, with the top line stuck in a narrow band between $9.863 billion and $10.364 billion over the past five quarters. Free cash flow is a concern: trailing twelve-month FCF is only $1.592 billion, yielding under 2% on the $81.8 billion market cap, and quarterly FCF has been highly volatile, swinging from -$3.63 billion in Q1 2026 to +$1.975 billion in Q2 2026. The current ratio of 0.704 indicates limited short-term liquidity cushion, and while the debt-to-equity ratio of 0.764 is moderate, it adds leverage risk if interest rates remain elevated.
Market and competitive risks are elevated given the stock's extreme valuation re-rating and recent momentum breakdown. The trailing PE has expanded 58% over two years to 15.56x, and price-to-book has risen to 1.85x from 1.10x, placing the stock near the top of its historical band. With a beta of 1.048, BNY is roughly as volatile as the broader market, but the recent 10.27% one-month decline and underperformance versus SPY (-10.86 percentage points) suggest stock-specific profit-taking. Competitive pressures in custody banking, including fee compression and fintech disruption, could erode BNY's market share, while regulatory changes affecting asset servicing or capital requirements pose additional headwinds.
The worst-case scenario involves a combination of revenue decline, multiple compression, and reduced capital return. If fee revenue continues to stagnate and the market reprices BNY's PE back to the 11-13x range seen in 2024-2025, the stock could fall toward the analyst low target of $135, representing 7.2% downside from the current $145.40. A more severe scenario, such as a recession or significant regulatory penalty, could push the shares toward the 52-week low of $103.11, implying a 29.1% loss. The maximum drawdown over the past period was -12.69%, but given the stock's 1,324% one-year gain, a deeper correction to $120 or lower is plausible if growth disappoints.
FAQ
The key risks for BNY are ranked as follows: 1) Revenue stagnation, with Q2 2026 revenue down 1.66% YoY, which could lead to multiple compression; 2) Weak free cash flow, with TTM FCF of $1.592 billion yielding under 2%, raising questions about the sustainability of buybacks and dividends; 3) Valuation risk, as the trailing PE of 15.56x is near historical highs and vulnerable to a re-rating to 11-13x; 4) Competitive and regulatory risks in the custody banking industry, including fee compression and potential fines. Additionally, the stock's beta of 1.048 means it is not immune to market downturns, and the recent 10.27% one-month decline shows it can correct sharply.
The 12-month forecast for BNY is neutral with a slight bullish bias. The base case (55% probability) targets a range of $145.40 to $166.93, assuming stable margins and flat revenue. The bull case (25% probability) targets $166.93 to $184.00, driven by revenue growth and multiple expansion. The bear case (20% probability) targets $103.11 to $135.00, reflecting revenue decline and PE compression. The most likely scenario is the base case, where BNY continues to deliver modest margin expansion and capital return but lacks a catalyst for significant upside. Key assumptions include revenue growth between -2% and +2% and continued buybacks of approximately $1 billion per quarter.
BNY appears fairly valued to slightly overvalued relative to its own history. The trailing PE of 15.56x is up 58% from 9.82x in Q2 2024, and the price-to-book ratio of 1.85x is near historical highs. However, the PEG ratio of 0.561 suggests the stock is undervalued relative to its earnings growth rate, and the forward PE of 14.17x is in line with large custody banks. The market is pricing in continued margin expansion and capital return, but with revenue stagnant, the valuation leaves little room for disappointment. A re-rating back to 11-13x PE would imply a stock price of $100-$120, representing significant downside.
BNY is a reasonable buy for income-oriented investors, but the risk/reward is balanced. The stock offers a 2.06% dividend yield with a low 30.37% payout ratio and trades at a forward PE of 14.17x, which is not expensive for a large-cap financial. Analyst consensus targets 14.8% upside to $166.93, but revenue declined 1.66% year-over-year in Q2 2026, and free cash flow yield is under 2%. The biggest downside risk is multiple compression toward the 11-13x PE range, which could push the stock to $135 or lower. For long-term investors comfortable with a mature, fee-based business, BNY is a solid holding, but near-term momentum is negative, so waiting for stabilization around $143 support could be prudent.
BNY is more suitable for long-term investment than short-term trading. The stock has a beta of 1.048, indicating market-level volatility, and its 1,324% one-year gain suggests it is prone to sharp corrections, as evidenced by the recent 10.27% one-month decline. The dividend yield of 2.06% and sustainable payout ratio of 30.37% make it attractive for income-focused investors with a horizon of at least 3-5 years. Short-term traders may find opportunities around earnings or support levels, but the lack of revenue growth and stretched valuation increase the risk of further downside. A minimum holding period of 2-3 years is recommended to ride out potential volatility and benefit from capital return.